ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Cubist Pharmaceuticals


Include trials that are no longer recruiting patients.

2 studies were found.
1.No longer recruitingDaptomycin for the Treatment of Infections Due to Gram-positive Bacteria
Condition: Gram-Positive Bacterial Infections
2.RecruitingDaptomycin in the Treatment of Subjects with Infective Endocarditis or Bacteremia due to S. aureus
Conditions: Bacterial Endocarditis; Bacteremia

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act